NASDAQ · Medical - Devices

SRTS (SRTS) Stock

$2.94 +1.03% NASDAQ: SRTS Healthcare

Valuation

MetricValue
Price$2.94
Market Cap$48.40M
P/E Ratio-7.06
P/B Ratio1.14
P/S Ratio2.43
EPS (TTM)$-0.47
52-Week High$5.92
52-Week Low$2.66
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-16.67%
ROA-15.09%
ROCE-20.83%
Gross Margin-40.74%
Operating Margin-37.04%
Net Margin-34.50%
Debt/Equity0.01
Current Ratio9.20

Annual Financials (USD)

Metric20212022202320242025
Revenue$27.0M$45.0M$24.0M$42.0M$27.0M
Operating Profit$4.0M$15.0M$0$8.0M$-10.0M
Net Profit$4.0M$24.0M$0$7.0M$-8.0M
EPS$0.25$1.46$0.03$0.41$-0.47
Op Margin15.2%33.3%-1.6%19.4%-37.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$32.0M$57.0M$54.0M$62.0M$53.0M
Total Liabilities$6.0M$9.0M$5.0M$6.0M$5.0M
Cash$15.0M$26.0M$23.0M$22.0M$22.0M
Borrowings$0$1.0M$1.0M$1.0M$1.0M

Latest News

Top Premarket Decliners MT Newswires · Jun 12, 2026 How The Sensus Healthcare (SRTS) Story Is Shifting With New Targets And 2026 Reimbursement Changes Simply Wall St. · May 20, 2026 Sensus Healthcare Q1 Earnings Call Highlights MarketBeat · May 9, 2026 Sensus (SRTS) Q1 2026 Earnings Transcript Motley Fool · May 7, 2026 Pleasing Signs As A Number Of Insiders Buy Sensus Healthcare Stock Simply Wall St. · May 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$-1.0M$-2.0M$-1.0M$1.0M
Investing Cash Flow$0$15.0M$0$-1.0M$0
Financing Cash Flow$0$-2.0M$0$0$0
Net Cash Flow$0$11.0M$-2.0M$-1.0M$0
Free Cash Flow$0$-2.0M$-2.0M$-1.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-1.14%
Quick Ratio4.45
Interest Coverage—
Return 1Y-26.64%
Return 3Y-0.29%
Return 5Y-21.60%

Ownership

Insiders Held17.63%
Institutions Held28.95%
Institutions Float Held35.14%
Institutional HolderSharesReport Date
Pacific Ridge Capital Partners, LLC796,0722026-03-31
Vanguard Capital Management LLC648,2252026-03-31
Dimensional Fund Advisors LP387,3922026-03-31
Divisadero Street Capital Management, LP286,0782026-03-31
Renaissance Technologies, LLC252,2342026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BDMD $1.07 +1.42% -1.68 $45.16M 0.00%
CTSO $0.35 -4.32% -3.62 $22.25M 0.00%
ICCM $2.88 +3.23% -1.00 $6.49M 0.00%
IPSC $2.02 -1.46% -5.04 $174.87M 0.00%
KPTIKaryopharm Therapeutics Inc. $7.60 +2.56% -0.50 $172.24M 0.00%

About SRTS

SRTS is led by CEO Joseph C. Sardano, employs 54 people, headquartered in US, publicly traded since 2016.

SRTS stock trades at $2.94 with a market capitalization of $48.40M. The stock is valued at a price-to-earnings (P/E) ratio of -7.06, price-to-book of 1.14, price-to-sales of 2.43. Over the past 52 weeks the stock has ranged between $2.66 and $5.92, and currently trades 50.3% below its 52-week high.

On profitability, SRTS generates a return on equity (ROE) of -16.67%, return on capital employed of -20.83%, an operating margin of -37.04%, a net profit margin of -34.50%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides